Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NRSNNRSN
9 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NEUROSENSE THERAPEUTICS LTD

CITADEL ADVISORS LLC previously held 0 shares of NRSN (NEUROSENSE THERAPEUTICS LTD), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$135,000

Total Shares Change

-55,119

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.25
0
2025-Q2
New
149,243
-
$282,0690.0%$1.90
36
2025-Q1
Exited
0
-100.0%
$00.0%$1.00
0
2024-Q4
Increased
253,997
+641.0%
$304,7960.0%$1.24
38
2024-Q3
New
34,280
-
$43,5360.0%$1.28
31
2023-Q4
Exited
0
-100.0%
$00.0%$0.79
0
2023-Q3
New
11,702
-
$8,7770.0%$0.71
26
2022-Q1
Exited
0
-100.0%
$00.0%$4.11
0
2021-Q4
New
55,119
-
$135,0000.0%$2.44
34

Other major holders of NRSN: JANE STREET GROUP, LLC, Hudson Bay Capital Management LP, MORGAN STANLEY, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used